AbClon Inc. (KOSDAQ:174900)
South Korea · Delayed Price · Currency is KRW 10,920
-410 (-3.62%)
Aug 1, 2025, 3:30 PM KST
AbClon Company Description
AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden.
The company’s products in pipeline include NEST platform technology products for breast and gastric cancers; AffiMab platform technology products for colon cancer and autoimmune diseases; and CAR-T platform technology products for hematologic and ovarian cancers.
AbClon Inc. was founded in 2010 and is based in Seoul, South Korea.
AbClon Inc.
| Country | South Korea |
| Founded | 2010 |
| Industry | Biological Products, Except Diagnostic Substances |
Contact Details
Address: 1401 285, Digital-ro Seoul, 08381 South Korea | |
| Phone | 82 2 2109 1294 |
| Website | abclon.com |
Stock Details
| Ticker Symbol | 174900 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7174900001 |
| SIC Code | 2836 |